Partner Nikki Gifford gave a presentation entitled “Intellectual Property – Recent Developments and Implications,” at the World Biosimilar Congress in San Diego, California, on Wednesday, May 24, 2017. The 30-minute session covered: (1) the BPCIA’s “patent dance”; (2) what’s at stake in Sandoz v. Amgen, and the potential outcomes and practical implications of the Supreme Court’s decision; and (3) how IPRs can provide a strategic alternative to litigation for key patents.

The slides presented can be found here. To learn more about Nikki and her practice, please find her bio here. To contact Nikki with any questions, she can be reached at ngifford@rfem.com.